Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study

Autor: Gwynivere A. Davies, John E. Orav, Kristen D. Brantley

Publikováno v: Current Oncology, Vol 31, Iss 7, Pp 3885-3894 (2024)

Cost-effectiveness analyses are required for therapies within Canada’s universal healthcare system, leading to delays relative to U.S. healthcare. Patients with Hodgkin lymphoma (HL) generally have an excellent prognosis, but those who relapse afte

Externí odkaz: https://doaj.org/article/fe4920bdbc93419c9f09af4fa021d8fc

Plasma Metabolomics and Breast Cancer Risk over 20 Years of Follow-up among Postmenopausal Women in the Nurses' Health Study

Autor: Kristen D. Brantley, Oana A. Zeleznik, Bernard Rosner, Rulla M. Tamimi, Julian Avila-Pacheco, Clary B. Clish, A. Heather Eliassen

Publikováno v: Cancer Epidemiol Biomarkers Prev

Background: Metabolite profiles provide insight into biologic mechanisms contributing to breast cancer development. We explored the association between prediagnostic plasma metabolites (N = 307) and invasive breast cancer among postmenopausal women i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893aa0a3a902bd04ce053a0227234b54
https://doi.org/10.1158/1055-9965.epi-21-1023

A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses’ Health Studies

Autor: Kristen D. Brantley, Oana A. Zeleznik, Barbra A. Dickerman, Raji Balasubramanian, Clary B. Clish, Julian Avila-Pacheco, Bernard Rosner, Rulla M. Tamimi, A. Heather Eliassen

Publikováno v: Br J Cancer

BACKGROUND: Adiposity is consistently positively associated with postmenopausal breast cancer and inversely associated with premenopausal breast cancer risk, though the reasons for this difference remain unclear. METHODS: In this nested case–contro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77814fd8410b4b9069e71297ab867844
https://europepmc.org/articles/PMC9470549/

Abstract 3022: Prospective study of circulating metabolomic signatures and breast cancer incidence among predominantly premenopausal women

Autor: Tengteng Wang, Oana Zeleznik, Emma E. McGee, Kristen D. Brantley, Raji Balasubramanian, Bernard A. Rosner, Walter C. Willett, Clary B. Clish, A. Heather Eliassen

Publikováno v: Cancer Research. 83:3022-3022

Background: Metabolomics has become a powerful tool to systematically examine metabolic pathways involved in carcinogenesis. Although several epidemiological studies examined the association between metabolites and breast cancer risk, metabolomic bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::58ad8a70dcc757277e70e25e87abbaac
https://doi.org/10.1158/1538-7445.am2023-3022

The association of serum lipid levels with colorectal cancer recurrence

Autor: Timothy L. Lash, Kristen D. Brantley, Anders H. Riis, Rune Erichsen, Ole Thorlacius-Ussing, Holger Jon Møller

Publikováno v: Brantley, K D, Riis, A H, Erichsen, R, Thorlacius-Ussing, O, Møller, H J & Lash, T L 2020, ' The association of serum lipid levels with colorectal cancer recurrence ', Cancer epidemiology, vol. 66, 101725 . https://doi.org/10.1016/j.canep.2020.101725

Background Biologic and epidemiologic evidence suggests that tumor cells depend on reprogrammed lipid metabolic function for survival and growth. Lipids may promote tumor recurrence by providing energy needed for proliferation. Studies have found ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7f8da5769eaf815736da42cb8d0277
https://vbn.aau.dk/da/publications/b7cf5d3d-a8e8-4233-b6c9-c6941275f8e9